Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

N Engl J Med. 2001 Apr 5;344(14):1052-6. doi: 10.1056/NEJM200104053441404.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Fluorodeoxyglucose F18
  • Fusion Proteins, bcr-abl / antagonists & inhibitors*
  • Humans
  • Imatinib Mesylate
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Magnetic Resonance Imaging
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy
  • Piperazines / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Pyrimidines / therapeutic use*
  • Sarcoma / diagnosis
  • Sarcoma / drug therapy*
  • Sarcoma / secondary
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / pathology
  • Stromal Cells
  • Tomography, Emission-Computed

Substances

  • Antineoplastic Agents
  • Benzamides
  • Enzyme Inhibitors
  • Piperazines
  • Pyrimidines
  • Fluorodeoxyglucose F18
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Fusion Proteins, bcr-abl